Intraventricular Administration of Substance P Induces Unattached Purkinje Cell Dendritic Spines in Rats

References

• Armstrong D., Terry R. D. Substance P immunoreactivity within neuritic plaques. Neuroscience Letters 1986; 58: 139–144
   Web of Science ®Google Scholar
• Baloyannis S. J., Gonatas N. K. Distribution of anti-HRP antibodies in CNS of immunized rats after disruption of the blood brain barrier. Journal of Neuropathology experimental Neurology 1979; 38: 519–531
   PubMed Web of Science ®Google Scholar
• Baloyannis S. J., Kim S. U. Experimental modification of cerebellar development in tissue culture: X-irradiation induces granule cell degeneration and unattached Purkinje cell dendritic spines. Neuroscience Letters 1979; 12: 283–288
   PubMed Web of Science ®Google Scholar
• Baloyannis S. J., Kim S. U. Morphological alteration of Purkinje cell axons and presynaptic terminals in organotypic cerebellar cultures exposed to ionizing irradiation. Acta Neuropathologica (Berlin) 1981; 54: 301–310
   PubMed Web of Science ®Google Scholar
• Baloyannis S. J., Karakatsanis K., Apostolakis M., Diacoyannis A. Effects of fGABA, glycin and sodium barbiturate on dendritic growth in vitro. Acta Neuropathologica (Berlin) 1983; 59: 171–182
   PubMed Web of Science ®Google Scholar
• Beal N. F., Masurek M. Substance P like immunoreactivity is reduced in Alzheimer's desease cerebral cortex. Neurology 1987; 37: 1205–1207
   PubMed Web of Science ®Google Scholar
• Beech T. G., Mc Greer E. G. Neocortical substance P neurons in the baboon: an immunohistochemical finding. Neuroscience Letters 1983; 41: 265–270
   PubMed Web of Science ®Google Scholar
• Brown J. R., Hill R. G. Multiple receptors for substance P. Trends in Neuroscience 1983; 4: 512–514
   Google Scholar
• Brownstein M. J., Mroz E. A., Tappaz M. L., Leeman S. E. On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Research 1977; 135: 315–323
   PubMed Web of Science ®Google Scholar
• Chang M. M., Leeman S. E. Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. Journal of Biological Chemistry 1970; 245: 4784–4790
   PubMed Web of Science ®Google Scholar
• Chang M. M., Leeman S. E., Niall H. D. Amino acid sequence of substance P. Nature 1971; 232: 86–87
   PubMed Web of Science ®Google Scholar
• Cheramy A., Michelot R., Leviel V., Nieoullon A., Glowinski J., Kerdelhue B. Effect of the immunoneutralization of substance P in the cat substantia nigra on the release of dopamine from dendrites and terminals of dopaminergic neurons. Brain Research 1978; 155: 404–408
   PubMed Web of Science ®Google Scholar
• Constantinides J., Bouras C., Richard J. Putative peptide neurotransmitters in human neuropathology. Topography and clinical implication. Clinical Neuropathology 1983; 2: 47–54
   PubMed Web of Science ®Google Scholar
• Crystal H. A., Davies P. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of Alzheimer's type. Journal of Neurochemistry 1982; 38: 1781–1784
   PubMed Web of Science ®Google Scholar
• Espamer V. The tachykinin peptide family. Trends in Neuroscience 1981; 4: 267–269
   Web of Science ®Google Scholar
• Harmar A., Schofield J. G., Keer P. Substance P biosynthesis in dorsal root ganglia: an immunochemical study of 35J methionin and 3H proline incorporation in vitro. Neuroscience 1981; 6: 1917–1922
   PubMed Web of Science ®Google Scholar
• Hartkop T., Jones M. Methylazoxymethanol induced aberrant Purkinje cell dendritic development. Journal of Neuropathology & Experimental Neurology 1977; 36: 519–532
   PubMed Web of Science ®Google Scholar
• Hartung H. P., Heininger K., Scaefer B., Toyka K. Substance P stimulates release of arachidonic acid cycloxygenation products from primary cultured rat astrocytes. Annals N. Y. Academy Science 1988; 540: 427–429
   PubMedGoogle Scholar
• Herndon R. M. Thiopen induced granule cell necrosis in the rat cerebellum. An electron microscopic study. Experimental Research 1969; 6: 49–68
   Google Scholar
• Herndon R. M., Margolis G., Hilham L. The synaptic organization of the malformed cerebellum induced by perinatal infection with the feline panleucopenic virus (PLV) V. The Purkinje cells and their afferents. Journal of Neuropathology & Experimental Neurology 1971; 30: 557–570
   PubMed Web of Science ®Google Scholar
• Hirano A., Dembitzer H. M., Jones M. An electron microscopic study of cycasin induced cerebellar degeneration. Journal of Neuropathology & Experimental Neurology 1972; 31: 113–125
   PubMed Web of Science ®Google Scholar
• Hirano A., Dembitzer H. M. Observation of the development of the weaver mouse cerebellum. Journal of Neuropathology & Experimental Neurology 1974; 33: 354–364
   PubMed Web of Science ®Google Scholar
• Hokfelt T., Meyerson B., Nillson G., Pernow B., Sachs C. Immunohistochemical evidence for substance P containing nerve endings in the human cortex. Brain Research 1976; 104: 181–186
   PubMed Web of Science ®Google Scholar
• Hokfelt T., Ljungdahl A., Terrentius L., Elde R., Nilsson G. Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: encephalin and substance P. Proceeding of National Academy USA 1977; 74: 3881–3885
   Web of Science ®Google Scholar
• Igwe O., Sum X., Larson A. Role of substance P amino-terminal metabolites in substance P induced desensitization in mice. Neuroscience 1990; 36: 535–542
   PubMed Web of Science ®Google Scholar
• Kim S. U., Pezeshkrour G. Unattached Perkinje cell dendritic spines in cytosin arabinoside treated mice. Journal of Neuropathology & Experimental Neurology, 35: 112
   Google Scholar
• Lavielle S., Chassaing G., Julien S., Besseyre J., Marquet A. The influence of the amino acids of substance P in the recognition of receptor affinities of synthesized SP analogues for the specific 125J-BHSP binding sites on the brain synaptosomes. Neuropeptide 1986; 7: 191–200
   PubMed Web of Science ®Google Scholar
• Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation Nauyn-Schmiedelberg's. Archives Pharmacology 1981; 310: 175–183
   Google Scholar
• Louis J. C., Rougeot C., Bepoldin O., Vulliez B., Mandel P., Dray L. Presence of somatostatin, encephalin and substance P-like peptides in cultural neurons from embryonic chick cerebral hemispheres. Journal of Neurochemistry 1983; 41: 930–938
   PubMed Web of Science ®Google Scholar
• Maggio J. Tachykinins. Annals Review Neuroscience 1988; 11: 13–28
   PubMed Web of Science ®Google Scholar
• Mal J. K., Stephens P., Hopf A., Cuello A. C. Substance P in human brain. Neuroscience 1986; 17: 709–739
   PubMed Web of Science ®Google Scholar
• Manolides L., Baloyannis S. J. The neuropeptides in the acoustic cortex. 1. Substance P. Acta Otolaryngology (Stockh.) 1987; 103: 481–488
   PubMed Web of Science ®Google Scholar
• Manolides L., Baloyannis S. J., Manolides S. Substance P increase the polymorphism of the synaptic vesicles in the temporal isocortex cultured in vitro. Acta Otolaryngology (Stockh.) 1988; 105: 500–506
   PubMed Web of Science ®Google Scholar
• Manolides L., Baloyannis S. J., Manolides S. Substance P in the acoustic area of the cortex during neuronal development and maturation. Acta Otolaryngology (Stockh.) 1989; 107: 375–382
   PubMed Web of Science ®Google Scholar
• Matsumoto S., Goto S., Mizusawa H., Hirano A. Immunohistochemical study of substance P and methencephalin in the globus pallidus of progressive supranuclear palsy (PSP). Journal of Neuropathology & Experimental Neurology 1989; 48: 325
   Web of Science ®Google Scholar
• Maurien-Mathieu A. M., Colonnier M. The molecular layer of the adult cat cerebellar cortex after lesion of the parallel fibers: an optic and electron microscopic study. Brain Research 1969; 16: 307–323
   PubMed Web of Science ®Google Scholar
• Melis M. R., Gale K. Evidence that nigral substance P controls the activity of the nigrotectal GABA-ergic pathway. Brain Research 1984; 295: 389–393
   Web of Science ®Google Scholar
• Mroz E. A., Brownstein M. J., Leeman S. E. Evidence for substance P in the habenu-lointerpeduncular tract. Brain Research 1976; 113: 597–599
   PubMed Web of Science ®Google Scholar
• Mroz E. A., Brownstein M. J., Leeman S. E. Evidence for substance P in the striatonigral tract. Brain Research 1977; 125: 305–311
   PubMed Web of Science ®Google Scholar
• Nakata Y., Kusaka Y., Yajima H., Segawa T. Active uptake of substance P carboxy terminal heptapeptide (5–11) into rat brain and rabbit spinal cord slices. Journal of Neurochemistry 1981; 37: 1529–1534
   PubMed Web of Science ®Google Scholar
• Nicoll R. A., Schenker C., Leeman S. E. Substance P as a transmitter candidate. American Review Neuroscience 1980; 3: 227–268
   PubMed Web of Science ®Google Scholar
• Nielson J., von Euler A. M., Dalsgaard C. J. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985; 315: 61–63
   PubMed Web of Science ®Google Scholar
• Payan D. G. Receptor-mediated mitogenic effects of substance P on cultured smooth muscle cells. Biochemistry, Biophysics, Research Communication 1985; 130: 104–109
   PubMed Web of Science ®Google Scholar
• Payan D. G., McGillis J. P., Renold F. K., Mitsubashi M., Goetzl E. J. Neuropeptide modulation of leucocyte function. Annals of New York Academy of Science 1987; 496: 182–191
   PubMed Web of Science ®Google Scholar
• Payan D. G., McGillis J. P., Renold F. K., Mitsunashi M., Goetzl E. J. The immunomodulating properties of neuropeptides. Hormones and immunity, J. Berczi, K. Kovacs. MTP Press, Nowell MA 1987; 203–214
   Google Scholar
• Payan D. G. Neuropeptides and inflammation: The role of substance P. Annals Review Medicine 1989; 40: 341–352
   PubMed Web of Science ®Google Scholar
• Pearson Brandeis J.L., Cuello A. C., Johnson E. Selective depletion of substance P in familial dysautonomia and nerve growth factor deprived animals. Journal of Neuropathology & Experimental Neurology 1981; 40: 339
   Web of Science ®Google Scholar
• Pearson J., Brandeis L., Cuello A. C. Depletion of substance P containing axons in substantia gelatinosa of patients with diminished pain sensitivity. Nature 1982; 295: 61–63
   PubMed Web of Science ®Google Scholar
• Pearson J., Goldstein M., Brandeis L., Guello A. Complexity of human mesencephalic catecholamine neurons and substance P terminals: change in diseases. Journal of Neuropathology & Experimental Neurology 1982; 41: 361
   Web of Science ®Google Scholar
• Pradelles P., Gross C., Humbert J., Dray F., Ben-Ami Y. Visual deprivation decreases met-encephalin and substance P content of various forbrain structures. Brain Research 1979; 1966: 191–193
   Google Scholar
• Quigley B. J., Kowall N. W. Substance P-like immunoreactivity neurons are depleted in Alzheimer's disease cerebral cortex. Neuroscience 1991; 41: 41–60
   PubMed Web of Science ®Google Scholar
• Reid M. S., Herrera-Marschitz M., Hokfelt T., Ohlin M., Valentino K. L., Ungerstedt U. Effects of intranigral substance P and neurokinin A on striatal Dopamine release-I Interactions with substance P antagonists. Neuroscience 1990; 36: 643–658
   PubMed Web of Science ®Google Scholar
• Sharma S. H., Nyberg F., Olsson Y., Dey P. K. Alteration of substance P after trauma to the spinal cord: an experimental study in the rat. Neuroscience 1990; 38: 205–212
   PubMed Web of Science ®Google Scholar
• Sharp T., Zetterstorm T., Ungerstedt U. An in vivo study of dopamine release and metabolism in rat brain regions using intracereral dialysis. Journal of Neurochemistry 1986; 47: 113–122
   PubMed Web of Science ®Google Scholar
• Staubli U., Huston J. Facilitation of learning by post-trial injection of substance P into the medial septal nucleus. Behavioral Brain Research 1980; 1: 245–255
   PubMed Web of Science ®Google Scholar
• Torrens Y., Beaujouan J., Saffroy M., Daquet de Mocety M., Berstrom L., Glowinski J. Substance P receptors in primary cultures of cortical astrocytes from the mouse. Proceedings of National Academy of Science USA 1986; 83: 9216
   PubMed Web of Science ®Google Scholar
• Van Winersma Greidanus, Maigert C. Grooming behavior induced by substance P. European Journal of Pharmacology 1988; 154: 217–220
   PubMed Web of Science ®Google Scholar
• Vincent S. R., Satoh K., Armstrong D. M., Fibiger H. C. Substance P in ascending cholinergic reticular system. Nature 1983; 306: 588–691
   Web of Science ®Google Scholar
• von Euler V. S., Gaddum J. H. An unidentified depressor substance in certain tissue extracts. Journal of Physiology 1931; 72: 577–583
   Google Scholar